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Summary. Many psoriatic arthritis patients do not progress to permanent joint damage in any
of the 28 hand joints, even under prolonged follow-up. This has led several researchers to
fit models that estimate the proportion of stayers (those who do not have the propensity to
experience the event of interest) and to characterize the rate of developing damaged joints in
the movers (those who have the propensity to experience the event of interest). However, when
fitted to the same data, the paper demonstrates that the choice of model for the movers can lead
to widely varying conclusions on a stayer population, thus implying that, if interest lies in a stayer
population, a single analysis should not generally be adopted.The aim of the paper is to provide
greater understanding regarding estimation of a stayer population by comparing the inferences,
performance and features of multiple fitted models to real and simulated data sets. The models
for the movers are based on Poisson processes with patient level random effects and/or dynamic
covariates, which are used to induce within-patient correlation, and observation level random
effects are used to account for time varying unobserved heterogeneity. The gamma, inverse
Gaussian and compound Poisson distributions are considered for the random effects.
Keywords: Intermittent observations; Longitudinal count data; Mover–stayer model; Poisson
process; Psoriatic arthritis; Random effects
1. Introduction
In psoriatic arthritis, several researchers (Aguirre-Herna´ndez andFarewell (2004), Solis-Trapala
and Farewell (2005) and recently O’Keeffe et al. (2012)) have considered the existence of a stayer
population (those who do not have the propensity to experience the event of interest) with re-
gard to clinical joint damage, after having discussed the clinical plausibility of such a population
with ProfessorDafnaGladman,whohas established the largest andmost comprehensively stud-
ied cohort of psoriatic arthritis patients in the world. If a subpopulation of stayers exists, the
identiﬁcation of characteristics that are associated with being a stayer would provide further
understanding of the disease, as would accounting for such a population when characterizing
the rate of developing damaged joints in the movers (those who have the propensity to experi-
ence the event of interest). Since these studies, there has been even more empirical evidence to
suggest that a stayer population may exist; many patients have remained damage free even after
further follow-up. Thus it now seems particularly appropriate to provide a more comprehensive
investigation into the existence of a stayer population.
Because the outcome is the occurrence of permanently damaged joints over time, mover–
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stayer counting process models will be considered as a useful framework for analysis. In the
literature, the models for the movers are typically constructed based on Poisson processes with
patient or observation level random effects; these act multiplicatively on the intensity for greater
ﬂexibility. In addition to these commonly proposed models, models with both patient and
observation level random effects and where the random effects are of a compound Poisson (CP)
form will also be considered. This paper demonstrates that, when ﬁtted to the same data (real
psoriatic arthritis data and simulated data), thesemodels can providewidely varying conclusions
on the existence and proportion of a stayer population, thus demonstrating that, as is commonly
done in the literature, a single analysis of a stayer population should not generally be adopted
uncritically. In light of these results and given the prevalence of longitudinal count data with
excess 0s, this paper aims to provide greater understanding of mover–stayer counting process
models, particularly relating to estimation of the stayer proportion, by comparing the inferences,
performance and model features of many models ﬁtted to real and simulated data sets. We note
that these results are analogous to those obtained on cure rate models (Boag, 1949; Farewell,
1977, 1982, 1986;Gordan, 1990;Ghitany et al., 1994)where it hasbeen shown that the estimateof
the cured fraction can be quite sensitive to the choice of the survival distribution (Yu et al., 2004).
Aguirre-Herna´ndez and Farewell (2004) and Solis-Trapala and Farewell (2005) have previ-
ously used mover–stayer counting process models to investigate the existence of a stayer popu-
lation that does not develop damaged joints. They considered models for the movers based on
introducing independent gamma random effects into Poisson process (Kingman, 1992) models
at the observation and patient level respectively. By comparing inferences with their respective
non-mover–stayer model, neither of these investigations found any convincing evidence for a
stayer population. The former analysis was performed at the total joint level, using the over-
all total joint count, whereas the latter was performed at the total joint level, using only the
counts for the hand joints. O’Keeffe et al. (2012) took a different approach based on the use
of mover–stayer multistate models at the individual hand joint level. They considered several
patient level random-effects distributions, the gamma, inverse Gaussian (IG) and CP distribu-
tion, and demonstrated large discrepancies in the estimates for the probability of being a stayer
(in the hands) across the different random-effects distributions. In particular, the use of patient
level gamma random effects in the model for the movers produced little evidence for a stayer
population, whereasmore convincing evidence was foundwhen patient level IG andCP random
effects were used instead. Although the analyses performed byAguirre-Herna´ndez andFarewell
(2004), Solis-Trapala and Farewell (2005) and O’Keefe et al. (2012) were on different versions of
the same data set and the modelling approach of O’Keeffe et al. (2012) was different (multistate
models as opposed to counting process models), the discrepancies across the various random-
effects distributions may suggest that the results of Aguirre-Herna´ndez and Farewell (2004) and
Solis-Trapala and Farewell (2005) were linked to the choice of gamma random effects and that,
if a different random-effects distribution was chosen, vastly different results and conclusions
may have occurred. This paper builds on this important issue (different random-effects distri-
butions providing vastly different conclusions on a stayer population) observed by O’Keeffe
et al. (2012) by also considering other random-effects structures, so that the results are more
general or relevant to the count data setting, and additionally considering model performance
and simulation studies to provide greater understanding.
The next section introduces the psoriatic arthritis data on which this analysis is based.
2. Psoriatic arthritis and the data
Psoriatic arthritis is an inﬂammatory arthritis associated with psoriasis. A basic measure of
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disease progression in psoriatic arthritis is the number of permanently damaged joints. Apart
from the damage process being permanent (once a joint becomes damaged it will remain so),
damaged joints can ultimately lead to disability and a reduced quality of life (Husted et al.,
2001; Kane et al., 2003). It is therefore important to prevent or slow the damage process where
possible. The main strategy employed by clinicians is to reduce activity in the joints (swelling
and/or pain in the joints) as this is widely believed to result in or to cause joint damage (O’Keeffe
et al., 2011). This paper focuses on the 28 joints in the hands (14 joints in each hand), which
can result in severe disability if damaged. Analyses will be based on data from the University
of Toronto psoriatic arthritis clinic which, since its inception in 1978 until the start of 2013, has
followed over 1000 patients with clinic visits scheduled approximately 6–12 months apart. At
each clinic visit, a physical examination, routine blood and urine tests and a rheumatological
assessment which includes a count of active and damaged joints are performed.
To produce a more homogeneous set of patients, we considered the 757 patients who entered
the clinic with no damaged hand joints and had more than a single clinic visit. Of these patients
422 (55.75%) were male and 335 were female (44.25%). At clinic entry, the mean age was 42.19
years, with a standard deviation of 12.48 years. The mean and median number of clinic visits
per patient were 11.27 and 7, and this ranged from 2 to 57. The mean age at onset of arthritis
was 36.76 years, with a standard deviation of 13 years. The mean follow-up time was 9.46 years,
with an interquartile range of 11.15 years. The mean and median intervisit times were 0.84 and
0.54 years, with a standard deviation of 1.19 years.
While in the clinic, a large percentage, 72% (524 patients), of these patients remained damage
free in the hand joints. Of the patients (233 patients) who developed damaged joints, the mean
rate of gaining damage was 0.53 joints per year (total number of damaged joints at the last clinic
visit or follow-up time in the clinic).
For this subset of the data, we consider models to estimate the proportion of stayers and to
characterize the rate of developing damage in the movers. Although the development of dam-
aged hand joints is not formally a recurrent events process (because there is a ﬁnite number of
hand joints), the models for the movers are based on Poisson processes, as an approximation,
with various random-effects structures and distributional assumptions. Heuristically, recurrent
events methodology was considered as a reasonable approximation because there are few oc-
casions where a large number of damaged hand joints have been observed, and therefore these
observations will contribute less in the analysis. More formal justiﬁcations are provided in Sec-
tions 3.4 and 5.2.
3. Patient level random-effects models and observation level random-effects
models
3.1. Patient level random-effects models
Let Dij =Nij+1 −Nij be the number of damaged joints that patient i has developed between
the jth and .j +1/th clinic visit. A natural ﬁrst choice would be to assume that Dij is Poisson
distributed with mean
uiΛij =ui.tij+1 − tij/λ0 exp.β′zij/
where ui is a realization of the patient level random effect Ui which induces correlation between
the observations of a patient, {tij}mij=0 are the times at which the clinic visits occurred, λ0 is
a constant baseline intensity and β and zij are column vectors of regression coefﬁcients and
covariates evaluated at the jth clinic visit respectively. To account for a subpopulation of stayers,
the distribution of Ui is taken to have a mixture distribution. Speciﬁcally the mover–stayer
672 S.Yiu, V. T. Farewell and B. D. M. Tom
random effects densities for Ui are of the form
gM−S.ui/=
{
πi, if ui =0,
f.ui/, if ui >0,
where πi is the probability that patient i is a stayer and f.ui/ is a truncated random-effect density
which integrates to 1−πi when patient i is a mover. The corresponding marginal likelihood
contribution from patient i is then{∫ ∞
0
mi−1∏
j=0
.uiΛij/dij exp.−uiΛij/
dij!
f.ui/dui
}ciÆ{
πi +
∫ ∞
0
mi−1∏
j=0
exp.−uiΛij/f.ui/dui
}1−ciÆ
where ciÆ = 0 if patient i remained damage free while in the clinic and ciÆ = 1 otherwise. The
likelihood is then constructed by taking the product of all likelihood contributions frompatients
in the data set. Models corresponding to a likelihood of this form will be referred to as Poisson
mover–stayer models and further qualiﬁcation, when needed, will be through the addition of
the type of random-effects distribution used.
Subsequently, the three different random-effects distributions that were used by O’Keeffe
et al. (2012) will be considered. The ﬁrst two random-effects distributions are of the form
gM−S.ui/=
{
πi, if ui =0,
.1−πi/g.ui/, if ui >0,
where g.ui/ has either a gamma density with rate and shape parameter 1=θ or an IG density
with mean 1 and shape parameter ψ, i.e.
g.ui|θ/= .1=θ/
1=θ
Γ .1=θ/
u
1=θ−1
i exp
(
− ui
θ
)
or
g.ui|ψ/=
(
ψ
2πu3i
)1=2
exp
{
− ψ.ui −1/
2
2ui
}
:
These two distributions will be referred to as the mover–stayer gamma and mover–stayer IG
models respectively. The third mover–stayer random-effects density is a CP density of the form
Ui =
Ni∑
j=1
Xj,
where Ni is a Poisson random variable with rate parameter ρi and Xj (j = 1, : : : ,Ni) are inde-
pendently and identically distributed gamma random variables with shape and rate parameters
1 and ν respectively. The density is given by
gM−S.ui/=
{
exp.−ρi/, if ui =0,
exp.−ρi −νui/√.νρi=ui/I1{2√.νρiui/}, if ui >0,
where I1.h/ is a modiﬁed Bessel function of the ﬁrst kind, i.e.
I1.h/=
∞∑
k=0
1
kΓ.k+2/
(
h
2
)2k+1
:
Aalen (1992) and Moger (2004, 2005) have provided applications of the CP distribution to
survival studies.
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Another commonly used random-effects distribution for the positive part is the log-normal
distribution. It can, however, be shown that this distribution is very similar to an IG distribution
and hence we do not consider its use here as it affords less tractability. See Chhikara and Folks
(1977) for more details.
It is also worth noting that there is a more general distribution which has the gamma, IG and
CP distributions nested in its family. The power variance family function is a three-parameter
family that was introduced by Hougaard (1986) and extended in Hougaard (2000). Its density
and Laplace transform are
g.u|m, ν,ρ/= exp.−ρ−νu/1
u
∞∑
j=1
ρj.νu/mj
Γ.mj/j!
and
L.s,m, ν,ρ/= exp
[
−ρ
{
1−
(
ν
ν + s
)m}]
where m > −1, ν > 0 and mρ > 0. When ρ → ∞ and m → 0 at a rate such that ρm → η, the
gamma distribution results. For the cases where m=− 12 and m>0, the IG and CP distributions
arise. In certain more tractable situations, i.e. when its Laplace transform is only required, the
parameter m can be estimated directly, thus providing information on the existence (m>0) or
non-existence (m0) of a stayer population. Note that the special case of m=1 corresponds to
the CP distribution that is used in this paper.
3.2. Observation level random-effects models
The Poisson mover–stayer models are derived by conditioning on a single random effect for
each patient to give conditionally independent contributions from a patient’s data. This induces
a correlation structure between the observations of a patient. This patient-speciﬁc random ef-
fect Ui might be thought of as accounting for missing time invariant variables that generate
heterogeneity across patients. It is, however, plausible that such unobserved variables are not
constant with time, especially when the follow-up periods are as long as in the psoriatic arthritis
data set. For example a patient’s prescribed medication, which is administrated at each clinic
visit, can dramatically change with time. Another commonly adopted approach would be to
retain an individual-speciﬁc probability of being at no risk of damage, πi, but to condition each
observation frompatients at risk on a different random effectUij drawn froman appropriate dis-
tribution. This would allow the unobserved heterogeneity across patients to vary with time also.
If this approach is adopted, some adjustment for the correlation between the observations
on the same patient, if they are at risk of damage, can be induced by inclusion of the observed
dynamic variableNij, which speciﬁes the attainednumber of damaged joints at the jth visit. Thus
the assumption becomes one of independence between incremental damage observations from
the same patient given this observed dynamic variable and the patient being in the at-risk group.
More formally, Dij is assumed Poisson distributed with mean
ciuijΛij = ciuij.tij+1 − tij/λ0 exp.β′zij/,
where
ci =
{
1, with probability 1−πi,
0, with probability πi,
indicateswhether the ith patient is amover (ci =1) or stayer (ci =0). The correspondingmarginal
likelihood contribution from patient i is then
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.1−πi/
mi−1∏
j=0
∫ ∞
0
.uijΛij/dij exp.−uijΛij/
dij!
g.uij/duij
}ciÆ
×
{
πi + .1−πi/
mi−1∏
j=0
∫ ∞
0
exp.−uijΛij/g.uij/duij
}1−ciÆ
:
The dynamic variable Nij enters through being an element in zij. Note that the integration
over the random effects that is required in the marginal likelihood contribution of patient i is
performed at the observation structural level and therefore mi integrations are required. This
contrasts with the marginal likelihood for the Poisson mover–stayer models which contained a
patient level random effect for which a single integration was performed over the contributions
from all observations on a single patient. Although these models are again of the mover–stayer
structure, theywill be referred to as zero-inﬂatedmodels for consistencywith the literature.Note
that the 0-inﬂation is at the patient and not observation level (i.e. ci and not cij is considered) and
therefore a patient can only be either a stayer or a mover throughout their follow-up. Further
qualiﬁcation of the zero-inﬂatedmodels will again be through themarginal models that are used
for patients in the at-risk category.
3.3. Model fitting
For the Poisson mover–stayer models, the gamma and IG distributional parts of the mover–
stayer random-effects distributions were parameterized to have unit means to avoid identi-
ﬁability problems with the baseline intensity. An alternative, but mathematically equivalent,
approach to avoid non-identiﬁability was taken for the CP random-effects distribution which
has an expectation of ρi=ν; ρi and ν were allowed to vary freely with λ0 constrained to 1.
The three Poisson mover–stayer models corresponding to these three random-effects distri-
butions are referred to as the Poisson mover–stayer gamma, Poisson mover–stayer IG and the
Poisson mover–stayer CP models. The zero-inﬂated models were examined when g.uij/ was
taken separately to be gamma and IG distributions, resulting in the zero-inﬂated negative bino-
mial (ZINB) and zero-inﬂated Poisson IG (ZIPIG) models as they are commonly known in the
literature.The sameparameterizations for the gammaand IGdistributions fromSection3.1were
used, although their rate and shape parameters are denoted by θnbij and ψ
pig
ij respectively. Here
the subscripts on the dispersion parameters indicate the possible dependence on explanatory
variables from the ith patient at tij. The CP distribution was not considered as an observation
level random-effects distribution because a mass at zero exists in this distribution and hence
would represent the unrealistic scenario that a patient can be a stayer or mover at one point in
time and a mover or stayer at another. This is unlike the case when patient level random effects
are considered, where a single random effect speciﬁes whether a patient is a mover or stayer.
Parameter estimation for these and all subsequent models in this paper was achieved by
maximizing the log-likelihood function by using the ‘Broyden–Fletcher–Goldfarb–Shanno’ op-
timization technique (Broyden, 1970) in the statistical package R (R Core Team, 2015). The
analytic solutions to the integrals in the likelihood for the random-effects distributions that are
considered in this section can be found in the on-line appendix A. The conﬁdence intervals for
all parameters and quantities reported are 95% Wald intervals obtained from evaluating and
then inverting the observed information matrix at the maximum likelihood estimates.
The number of currently active (swollen and/or painful) joints, permanently attaineddamaged
joints, age at onset of arthritis (in years) and duration of arthritis (in years) were considered
as explanatory variables for the mean functions, and intercept-only models were considered for
the dispersion parameters, i.e. θnbij =θnb and ψpigij =ψpig.
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Table 1. Parameter estimates and corresponding 95% Wald intervals of associations with damaged joint
counts and stayer probability estimates obtained from fitting the Poisson mover–stayer (patient level ran-
dom-effects models) and zero-inflated models (observation level random-effects models) to 757 psoriatic
arthritis patients
Results for the following models:
Poisson mover– Poisson mover– Poisson mover– ZINB ZIPIG
stayer gamma stayer IG stayer CP
Attained number of −0:11 −0:12 −0:082 0.059 0.057
damaged joints .−0:13,−0:095/ .−0:14,−0:1/ .−0:097,−0:066/ (0.033, 0.084) (0.033, 0.081)
Current number of 0.061 0.06 0.064 0.095 0.097
active joints (0.047, 0.075) (0.046, 0.074) (0.051, 0.078) (0.068, 0.12) (0.072, 0.12)
Arthritis duration 0.07 0.074 0.045 0.0063 −0:0022
(0.056, 0.084) (0.059, 0.088) (0.033, 0.056) .−0:0063, 0:019/ .−0:016, 0:011/
Age at onset of 0.021 0.02 0.014 0.0078 −0:00045
arthritis (0.0051, 0.037) (0.0015, 0.038) (0.0031, 0.024) .−0:0031, 0:019/ .−0:012, 0:011/
λ0 0.034 0.052 1 0.1 0.16
(0.018, 0.065) (0.024, 0.12) (0.061, 0.17) (0.093, 0.27)
θ 6.19
(5.11, 7.5)
ψ 0.11
(0.066, 0.19)
ν 12
(6.68, 17.32)
ρ 0.58
(0.49, 0.67)
θnb 9.78
(8.1, 11.45)
ψpig 0.062
(0.048, 0.081)
π 9.1×10−4 0.32 0.56 0.43 0.44
(0, 1) (0.2, 0.47) (0.51, 0.61) (0.36, 0.5) (0.37, 0.51)
Log-likelihood −2689:03 −2676:34 −2741:55 −2279:36 −2273:27
All models were ﬁtted with πi = π so that the existence of a stayer population could be
more simply investigated, speciﬁcally, through testing the null hypothesis H0 : π = 0 for the
Poisson mover–stayer gamma, Poisson mover–stayer IG and the zero-inﬂated models. Under
the null hypothesis, the asymptotic distribution of the likelihood ratio test for these models
(against their non-mover–stayer counterpart) is a 50:50 mixture of a point mass at zero and a
χ21-distribution (Self andLiang, 1987).A test ofH0 :π=0 for thePoissonmover–stayerCPmodel
is equivalent to testing H0 : exp.−ρ/=0 (or H0 :ρ=∞). However, under this null hypothesis, the
parameter ν becomes irrelevant (see the on-line appendix B for details), which therefore results
in the asymptotic distribution of the likelihood ratio statistic being intractable. For this model,
consideration will initially be given to the 95% Wald interval of πˆ to reason about the existence
of a stayer population. It is also worth noting that models where πi depends on explanatory
variables can be developed. However, this would make sense only if reasonable evidence exists
for a subpopulation of stayers.
3.4. Results
Table 1 shows the results from the Poissonmover–stayer (patient level random-effects) and zero-
inﬂated (observation level random-effects) models ﬁtted to the Toronto psoriatic arthritis data
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described in Section 2. Within the class of Poisson mover–stayer and zero-inﬂated models, the
regression coefﬁcient estimates are quite similar; most estimates lie in the corresponding 95%
Wald interval of the other models. The current number of active joints, duration of arthritis and
age at onset of arthritis demonstrate signiﬁcant positive associations with damage progression
in the Poisson mover–stayer models, whereas the current number of active joints is seen to have
a signiﬁcant positive association in the zero-inﬂated models. The Poisson mover–stayer models
suggest that the attained number of damaged joints has a negative association with damage
progression whereas the zero-inﬂated models suggest a positive association. After accounting
for correlation through the multiplicative patient level random effect, it is natural to postulate
that the negative association is indicative of there being fewer joints having the propensity to
becomedamaged.Thiswould suggest that different resultsmayhavebeenobtained if the number
of joints that are at risk of damage was accounted for in the model (beyond inclusion of this
dynamic covariate). For this reason, truncated Poisson models and multistate models at the
individual joint level were ﬁtted; these models directly account for the number of joints that
are at risk of damage at each time point. Reassuringly, similar results were produced including
the signiﬁcant negative or positive association of the attained number of damaged joints when
patient or observation level random effects were included.Asmentioned, the attained number of
damaged joints was primarily introduced to provide information about the history of a patient
due to true contagion and is therefore introducing correlation between the patient observations.
As the patient level random effect is also designed to reﬂect partly this type of correlation
(in addition to capturing time invariant unobserved heterogeneity), the effect of this dynamic
covariate will probably be confounded with the random effects. For a detailed discussion on the
connection between frailty models and models with dynamic covariates see Aalen et al. (2008).
Fig. 1 shows plots of the proﬁle log-likelihoods forπ. FromFig. 1, the proﬁle log-likelihood for
thePoissonmover–stayer gammamodel is seen tobe amonotonically decreasing function,which
implies that themaximum is attained at the boundary, in particular at π=0, and not at the value
that is produced from the numerical optimization procedure (reported in Table 1). The Poisson
mover–stayer gamma model therefore suggests the non-existence of a stayer population. As the
optimization procedure did not converge at the maximum, a more relevant conﬁdence interval
(as opposed to a Wald interval) can be computed from the proﬁle likelihood based on values
of π in which the null hypothesis H0 :π =0 cannot be rejected. Such an interval was calculated
as .0, 0:063/. The optimization routine for the other models (Poisson mover–stayer IG and CP
models and zero-inﬂated models) seem to have converged at the maximums of their respective
proﬁle log-likelihoods. Furthermore, as the stayer proportions and their respective conﬁdence
intervals are estimated far from zero, these models are consistent with a stayer population.
A likelihood ratio test of H0 :π = 0 (as described in Section 3.3) resulted in p< 0:001 for the
Poisson mover–stayer IG and zero-inﬂated models therefore indicating convincing evidence for
a stayer population. From Table 1, it can, however, be seen that the stayer proportion estimates
are widely varying across these models.
3.5. Model performance
Because the ﬁtted models are non-nested, standard asymptotic theory does not support for-
mal hypothesis testing through comparison of likelihood values. Nevertheless, the zero-inﬂated
models are seen to have vastly larger likelihood values than the Poisson mover–stayer models.
This would indicate, informally, that the zero-inﬂated models provide a much improved ﬁt rela-
tive to the Poisson mover–stayer models. If, however, the goodness of ﬁt to the data is of speciﬁc,
standalone, interest (in addition to providing a means of model comparison), likelihood values
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Fig. 1. Plots of the profile log-likelihoods for π (, point at which the numerical optimization procedure
converged): (a) mover–stayer gamma; (b) mover–stayer IG; (c) mover–stayer CP; (d) ZINB; (e) ZIPIG
are less informative. Therefore, we compare the observed and estimated increments of damaged
joints. Let
eij.d/= Pˆ.Dij =d|zij, Λˆij/, d =0, 1, : : : ,
be the estimated probability that patient i develops d additional damaged joints between tij and
tij+1. Here Λˆij and πˆ are the maximum likelihood estimates that were obtained in Section 3.4.
For the Poisson mover–stayer models, Dij is assumed to have a Poisson distribution conditional
on ui. To obtain values of eij.d/ for these models, ui is estimated by using the empirical Bayes
estimate, speciﬁcally,
uˆi =E.Ui|λˆ0, βˆ, φˆ, zi, ti/
=
∫ ∞
0
ui f.ui|λˆ0, βˆ, φˆ, zi, ti/dui
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Table 2. Observed and estimated changes in joint counts from the Poisson mover–stayer and zero-inflated
models†
Increments of Observed Results for the following models:
damaged joints
Poisson mover– Poisson mover– Poisson mover– ZINB ZIPIG
stayer gamma stayer IG stayer CP
0 without previous 6044 5974.94 (0.8) 5987.57 (0.53) 5954.33 (1.35) 5974.52 (0.81) 5974.94 (0.8)
damage
0 with previous 2032 1871.25 (13.81) 1888.21 (10.95) 1861.51 (15.61) 2057.45 (0.31) 2050.72 (0.171)
damage
1 250 528.89 (147.06) 505.29 (128.98) 559.2 (170.97) 310.09 (11.64) 337.3 (22.6)
2 97 91.97 (0.27) 87.07 (1.13) 94.92 (0.05) 88.39 (0.84) 76.84 (5.29)
3 28 27.24 (0.02) 26.31 (0.11) 26.94 (0.042) 37.48 (2.4) 31.83 (0.46)
4 26 11.62 (17.77) 11.36 (18.85) 11.29 (19.16) 19.37 (2.27) 16.84 (4.98)
5 17 6.3 (18.14) 6.17 (19.03) 6.08 (19.58) 11.33 (2.83) 10.17 (4.58)
6 8 3.97 (4.08) 3.87 (4.41) 3.8 (4.63) 7.23 (0.08) 6.69 (0.26)
7 6 2.77 (3.78) 2.69 (4.07) 2.63 (4.32) 4.91 (0.24) 4.66 (0.38)
8 7 2.08 (11.68) 2.04 (12.08) 1.97 (12.79) 3.51 (3.48) 3.39 (3.83)
>8 15 8.97 (4.06) 9.42 (3.3) 7.33 (8.02) 15.72 (0.03) 16.61 (0.16)
Total 8530 8530 (221.49) 8530 (203.46) 8530 (256.52) 8530 (24.94) 8530 (43.51)
†The estimated changes of d joint counts are calculated as e.d/ =ΣiΣjeij.d/. In parentheses are the Pearson
statistic contributions. These are obtained by squaring the difference between the observed and estimated changes
and then dividing by the estimated changes.
where φˆ is the maximum likelihood estimate for the set of parameters of the random-effects dis-
tribution and f.ui|λˆ0, βˆ, φˆ, zi, ti/ denotes the predictive distribution of ui, which takes the form
f.ui|λˆ0, βˆ, φˆ, zi, ti/= Li.λˆ0, βˆ|ui; zi/gM−S.ui|φˆ/∫ ∞
0
Li.λˆ0, βˆ|ui; zi/gM−S.ui|φˆ/dui
:
Here Li.λˆ0, βˆ|ui; zi/ is the conditional likelihood contribution from the ith patient. For the
zero-inﬂated models, Dij is assumed to have a Poisson distribution conditional on uij and ci.
Hence Dij has a negative binomial (NB) or Poisson IG distribution conditional on ci if uij is
drawn from a gamma or IG distribution respectively. Values of eij.d/ can then be obtained by
using these marginal distributions and estimating ci by its empirical Bayes estimate, i.e.
cˆi = .1− πˆi/Li.λˆ0, βˆ|ci =1; zi/
.1− πˆi/Li.λˆ0, βˆ|ci =1; zi/+ πˆiLi.λˆ0, βˆ|ci =0; zi/
:
The observed and estimated changes in joint counts are displayed in Table 2. It is evident from
Table 2 that none of the Poisson mover–stayer models provide particularly close agreements be-
tween the observed and estimated values. The category with increments of one damaged joint
is considerably overestimated by all three models which then results in the majority of cate-
gories with larger increments of damaged joints being severely underestimated. However, the
zero-inﬂated models demonstrate much closer agreement, as also suggested by the likelihood
values, which may indicate that time varying unobserved heterogeneity is strongly present in
the data. The category corresponding to an increment of one damaged joint is overestimated
to a much lesser degree by these models and as a result categories with larger incremental dam-
age are underestimated less severely. One general statistic that accounts for the overall model
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performance at each category is the Pearson statistic. Let o.d/ denote the observed number
of times where d incremental damaged joints occurred and let e.d/ =ΣiΣjeij.d/. A Pearson
statistic can then be deﬁned as Σd{o.d/− e.d/}2=e.d/. This statistic was calculated as 221.49,
203.46 and 256.52 for the ﬁtted Poisson mover–stayer gamma, Poisson mover–stayer IG and
Poisson mover–stayer CP models and 24.94 and 43.51 for the ﬁtted ZINB and ZIPIG models
respectively.
The Pearson statistic distribution under the null hypothesis that the ﬁtted models are the
data-generating mechanisms can be used to assess more formally the goodness of ﬁt of the ﬁtted
models. The exact form of this distribution is obtained from summing the independent but
non-identically distributed eij.d/s which are of a multinomial form. This, however, results in an
intractable distribution. Alternatively, this distribution can be estimated by using a parametric
bootstrap algorithm such as that described in Aguirre-Herna´ndez and Farewell (2004), in which
a bootstrap data set s was simulated by ﬁrst simulating csi from a Bernoulli distribution with
success probability 1 − πˆ for each patient. If the realized value csi was 0, the patient was a
simulated stayer and therefore the simulated values dsij were 0 for all observed time intervals
for this patient. Otherwise, each value dsij was simulated given Λˆij and θˆ
nb
from an NB or ψˆ
pig
from a Poisson IG model. To simulate this dsij from these distributions, a value u
s
ij from either
a gamma or IG distribution with parameter θˆ
nb
or ψˆ
pig
is ﬁrst sampled; then dsij is drawn from
a Poisson distribution with mean usijΛˆij. The Pearson statistic can then be calculated for the
bootstrap data set by reﬁtting the same model structure onto this data set and calculating the
corresponding os.d/ and es.d/ for all d.
This procedure was repeated 1000 times, hence producing 1000 realizations of the Pearson
statistic under the null hypothesis that the ﬁtted model is the underlying data-generating mecha-
nism. The p-values for the models proposed are then calculated as being the proportion of these
realizations greater than the Pearson statistic evaluated on the observed data set. The p-values
for the ZINB and ZIPIG models were calculated as 0.098 and less than 0.001 with the means
of the bootstrap goodness-of-ﬁt distribution being 16.56 and 15.77 respectively. These results
suggest that there is little evidence of lack of agreement between the observed and estimated
incremental joint damage from the ZINB model. However, there is more evidence of lack of
agreement from the ZIPIG model.
4. Model features influencing estimation of π
In the previous sections, and as is commonly done in the literature, the parameter π was used
to investigate the existence and proportion of a stayer population as it represents a statistically
coherent framework. For example, one could test H0 :π=0 or examine its estimated conﬁdence
interval. In regard to the PA data, widely varying estimates of this parameter resulted when
differentmodels for themovers were speciﬁed. This, at the veryminimum,would suggest a single
analysis of a stayer population through π should not be adopted uncritically and that greater
consideration of this parameterwould beworthwhile. This section considerswhydifferent values
of π may have resulted by investigating the interpretability of such a parameter across the ﬁtted
models.
Across the ﬁtted models, it would be natural to postulate that patients who are highly likely or
unlikely to be stayers have similar stayer probability estimates and that the main discrepancies
from these estimates have resulted from disentangling slow transitioning movers and stayers.
This may suggest, because of the widely varying estimates of π, that the PA data contained
some patients who were slow transitioning movers and that the ﬁtted models distinguished very
differently between slow transitioning movers and stayers. If this is so, it would be intuitive
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to examine features of the ﬁtted models, especially the model structure for the movers which
generate the possibility and proportion of slow transitioning movers.
In the motivating application, both the Poisson mover–stayer IG and CP models strongly
suggest the existence of a stayer population. For these models, the continuous part of the
patient level random-effects densities are such that g.ui/ → 0 when ui → 0, regardless of the
parameter ψ (IG), and g.ui/→ρν exp.−ρ/ as ui →0 (CP). Thus it appears less likely that these
distributions can place a large proportion ofmass arbitrarily close to zero. If a slow transitioning
mover population exists, the Poisson mover–stayer IG and CP models may therefore struggle
to represent these patients adequately in the model for the movers, and hence these models
may attribute slow transitioning movers with high stayer probabilities instead, i.e. the stayer
proportions will be overestimated. Regarding the CP distribution, the parameter ρ, as discussed,
governs both the overall baseline transition intensity ρ=ν and the stayer proportion exp.−ρ/.
An overall slow or fast transition intensity, e.g. when there are many or few slow transitioning
movers, as indicated by ρ will then also enforce a high or low stayer probability (through ρ) even
if few or many stayers exist. This is not so for the other models as a slow or fast overall baseline
transition intensity .1−π/λ0 through λ0 will not force π to take a certain value.
The class of zero-inﬂated models also strongly suggests the existence of a stayer population.
These models, unlike the others, do not contain patient level random effects and therefore are
less able to represent speciﬁc patients with constantly low propensity of developing damage,
after adjusting for covariates. Hence, for these zero-inﬂated models, representing an arbitrary
number of slow transitioning movers may also be problematic, particularly more so than with
patient level random-effect models, and this will again probably result in slow transitioning
movers being attributed high stayer probabilities.
Of the ﬁtted models, only the Poisson mover–stayer gamma model suggests the non-existence
of a stayer population since πˆ = 0. This model was constructed by using patient level gamma
random effects in the model for the movers. Under the current parameterization for UiΛij, if
θ>1, the gamma distribution is such that g.ui/→∞ as ui →0, and therefore this distribution
can place a large proportion of mass arbitrarily close to zero. Implicitly, the gamma distribution
can represent a large proportion of patients with small transition intensities, namely the slow
transitioningmovers. In contrastwith the othermodels, thePoissonmover–stayer gammamodel
would seem to be at less risk of overestimating the stayer proportion; the stayer probabilities for
the slow transitioning movers are less likely to be overestimated. However, if sufﬁcient follow-
up information is not available, it is clear that identiﬁability issues will arise because stayers
can be reasonably represented either through π or the left-hand tail of the gamma distribution.
In the motivating application, the ﬁtted Poisson mover–stayer gamma model was such that
θˆ = 6:19 .5:11, 7:5/ with a small average estimated transition intensity. Thus this model seems
to have inferred a slow transitioning mover population, instead of attributing these patients as
stayers.
In summary, although π is deﬁned as those with no propensity to develop damage (i.e. λ=0),
this parameter seems to be heavily dependent on the model for the movers, at least for the
ﬁtted models, perhaps because it generates the possibility and proportion of slow transitioning
movers. At a minimum, this would suggest that a more appropriate interpretation of π would
be the proportion of patients who are at no or at least minimal risk of damage, which cannot be
adequately explained by the ﬁttedmodel for themovers, although the ﬁttedmodel for themovers
may not necessarily ﬁt well. This would be particularly relevant for the motivating application,
especially when considering the differences between the Poisson mover–stayer gamma model
and the others, because the model structures for the movers speciﬁed vastly different probability
distributions for the risk of damage.
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Table 3. Results of the simulation study under scenario 1†
Model πˆ (SE,SD) πˆ− πˆ PM−STrue % of simulations
(SD) where πˆ≈0
Poisson mover–stayer gamma (π=0.3,λ=0.5,θ=1)
Poisson mover–stayer gamma 0.29 (0.068, 0.07) — 0.5
Poisson mover–stayer IG 0.36 (0.041, 0.042) 0.071 (0.039) 0
Poisson mover–stayer CP 0.31 (0.04, 0.04) 0.021 (0.06) 0
ZINB 0.41 (0.035 0.035) 0.12 (0.055) 0
ZIPIG 0.41 (0.035, 0.035) 0.12 (0.055) 0
Poisson mover–stayer IG (π=0.3,λ=0.5,ψ=1)
Poisson mover–stayer gamma 0.21 (0.076, 0.077) −0.091 (0.048) 3.2
Poisson mover–stayer IG 0.3 (0.043, 0.043) — 0
Poisson mover–stayer CP 0.26 (0.038, 0.038) −0.043 (0.028) 0
ZINB 0.36 (0.034 0.034) 0.063 (0.019) 0
ZIPIG 0.36 (0.034, 0.034) 0.063 (0.019) 0
Poisson mover–stayer CP (π=0.3,ν =1)
Poisson mover–stayer gamma 0.3 (0.037, 0.037) 0.002 (0.018) 0
Poisson mover–stayer IG 0.31 (0.034, 0.034) 0.028 (0.008) 0
Poisson mover–stayer CP 0.3 (0.034, 0.031) — 0
ZINB 0.34 (0.03, 0.033) 0.034 (0.006) 0
ZIPIG 0.34 (0.033, 0.033) 0.034 (0.006) 0
ZINB (π=0.3,λ=0.3,θnb =4)
Poisson mover–stayer gamma 0.3 (0.056, 0.056) 0.004 (0.01) 0
Poisson mover–stayer IG 0.33 (0.045, 0.045) 0.023 (0.017) 0
Poisson mover–stayer CP 0.18 (0.042, 0.044) −0.12 (0.017) 0
ZINB 0.3 (0.044, 0.044) — 0
ZIPIG 0.3 (0.044, 0.044) 0.005 (0.001) 0
ZIPIG (π=0.3,λ=0.3,ψpig =0.5)
Poisson mover–stayer gamma 0.3 (0.04, 0.04) −0.003 (0.015) 8.2
Poisson mover–stayer IG 0.3 (0.04, 0.04) −0.002 (0.013) 0
Poisson mover–stayer CP 0.12 (0.038, 0.039) −0.18 (0.013) 0
ZINB 0.3 (0.039, 0.037) −0.001 (0.001) 0
ZIPIG 0.3 (0.039, 0.04) — 0
†The second column displays the mean and standard deviation SD of the estimated values of π together with the
mean standard error SE. The third column displays the mean and standard deviation of the estimated difference
between π from each model and π from the true model. The fourth column displays the percentage of simulations
where πˆ≈0.
4.1. Simulation study
To formalize ideas and to investigate estimation of π further by using the considered (and
commonly advocated) models, we perform some simulation studies. These studies will represent
the scenarios where there are few or many slow transitioning movers in addition to a stayer
population. In the ﬁrst scenario, where few patients are slow transitioning movers, a lesser
distinction between estimated values of π is expected, although possibly not for the Poisson
mover–stayer CP model. In the second scenario, where many slow transitioning movers exists,
there should be a greater distinction between the estimates of π, speciﬁcally between the Poisson
mover–stayer gamma model and the other models which are less able to represent an arbitrary
number of slow transitioning movers through the left-hand tail of their mover distribution.
In scenario 1, we simulate from the Poisson mover–stayer gamma, Poisson mover–stayer
IG, Poisson mover–stayer CP, ZINB and ZIPIG models with no covariates and {π = 0:3,λ=
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Table 4. Results of the simulation study under scenario 2†
Model πˆ (SE,SD) πˆ− πˆ PM−S true % of simulations
(SD) where πˆ≈0
Poisson mover–stayer gamma (π=0.3,λ=0.3,θ=4)
Poisson mover–stayer gamma 0:28 (0.23, 0.22) — 28.7
Poisson mover–stayer IG 0.59 (0.056, 0.056) 0.3 (0.18) 0
Poisson mover–stayer CP 0.61 (0.039, 0.039) 0.33 (0.21) 0
ZINB 0.67 (0.034, 0.033) 0.38 (0.21) 0
ZIPIG 0.67 (0.034, 0.033) 0.38 (0.21) 0
Poisson mover–stayer IG (π=0.3,λ=0.3,ψ=0.5)
Poisson mover–stayer gamma 0:061 (0.086, 0.085) −0:23 (0.065) 58.9
Poisson mover–stayer IG 0.3 (0.055, 0.055) — 0
Poisson mover–stayer CP 0.33 (0.039, 0.039) 0.37 (0.42) 0
ZINB 0.41 (0.035, 0.035) 0.11 (0.33) 0
ZIPIG 0.41 (0.035, 0.035) 0.11 (0.34) 0
Poisson mover–stayer CP (π=0.3,ν =4)
Poisson mover–stayer gamma 0:31 (0.064, 0.062) 0.01 (0.05) 0
Poisson mover–stayer IG 0.37 (0.042, 0.041) 0.07 (0.22) 0
Poisson mover–stayer CP 0.3 (0.041, 0.04) — 0
ZINB 0.42 (0.035, 0.035) 0.12 (0.011) 0
ZIPIG 0.42 (0.035, 0.034) 0.12 (0.011) 0
ZINB (π=0.3,λ=0.15,θnb =4)
Poisson mover–stayer gamma 0.28 (0.12, 0.12) −0:016 (0.1) 9.6
Poisson mover–stayer IG 0.32 (0.085, 0.084) 0.029 (0.06) 2.6
Poisson mover–stayer CP 0.16 (0.057, 0.058) −0:13 (0.035) 0
ZINB 0.29 (0.069, 0.07) — 0
ZIPIG 0.3 (0.068, 0.07) 0.005 (0.061) 0
ZIPIG (π=0.3,λ=0.15,ψpig =0.5)
Poisson mover–stayer gamma 0.27 (0.1, 0.1) −0:024 (0.08) 19.5
Poisson mover–stayer IG 0.29 (0.084, 0.08) −0:076 (0.062) 8.2
Poisson mover–stayer CP 0.091 (0.047, 0.048) −0:2 (0.03) 0
ZINB 0.29 (0.062, 0.064) −0:002 (0.002) 0
ZIPIG 0.29 (0.061, 0.063) — 0
†The column headings have the same interpretation as those stated in the footnote to Table 3.
0:3, θ = 4}, {π = 0:3,λ= 0:5,ψ = 1}, {π = exp.−ρ/= 0:3, ν = 4}, {π = 0:3,λ= 0:3, θnb = 4} and
{π=0:3,λ=0:3,ψpig =0:5} respectively. In scenario 2, we simulate from the same models with
no covariates and {π=0:3,λ=0:5, θ=1}, {π=0:3,λ=0:5,ψ=0:5}, {π=exp.−ρ/=0:3, ν =1},
{π = 0:3,λ= 0:15, θnb = 4} and {π = 0:3,λ= 0:15,ψpig = 0:5} respectively. Smaller values of λ
and/or greater values of θ, 1=ψ and ν were chosen in scenario 2 to generate the setting where
there would be more slow transitioning movers than in scenario 1. Simulations from the Poisson
mover–stayer models were performed by ﬁrst simulating usi for each patient. The damage joints
increments dsij were then simulated from aPoisson distributionwithmean u
s
iΛij. For the Poisson
mover–stayer gamma and IG models, usi was obtained from c
s
i v
s
i where c
s
i is a realization from a
Bernoulli distribution with success probability 1−π and vsi is a realization from either a gamma
or IG distribution with mean 1 and variance θ or 1=ψ respectively. For the Poisson mover–
stayer CP model, usi was obtained by simulating from a gamma distribution with rate ν and
shape nsi where n
s
i is generated from a Poisson distribution with mean ρ. Simulations from the
zero-inﬂated models were performed by simulating dsij from a Poisson distribution with mean
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csi u
s
ijΛij where c
s
i is as before and u
s
ij is a realization from either a gamma or IG distribution
with mean 1 and variance θnb or 1=ψpig respectively.
In both scenarios, 1000 data sets were simulated with each containing 200 patients. Each
patientwas assumed to have 11 clinic visits annually. The Poissonmover–stayer and zero-inﬂated
models were then ﬁtted to each data set.
Tables 3 and 4 display the results of the simulation study under scenario 1 and scenario
2 respectively. Only results on estimates of π are displayed although the baseline intensities
and dispersion parameters were also estimated. In both scenarios, there were some similar
characteristics to those seen in themotivating application. In particular, the zero-inﬂatedmodels
generally provide the highest stayer proportion estimates, and furthermore the estimates were
similar across the ZINB and ZIPIG models. However, across both scenarios, it is clear that
the stayer proportion estimates are considerably more biased in scenario 2, as indicated by the
difference in stayer proportion estimates from each model and the true model (the third column
in Tables 3 and 4). This is especially so when the Poisson mover–stayer gamma and IG models
are the true model. These results suggest that the model for the movers is particularly inﬂuential
in the estimation of π when there are many slow transitioning movers. Indeed, no model, on
average, could accurately estimate the true stayer proportion in all the settings in scenario 2. A
noteworthy observation can be made when the zero-inﬂated models are the true models. In this
case, the Poissonmover–stayerCPmodel estimates considerably smaller stayer proportions than
the other models which are in close agreement with one another. The zero-inﬂated models in
these simulation settings cannot generate patient-speciﬁc propensities for damage since patient
level random effects or dynamic covariates are not included in these models. Moreover, they
can generate only independent observation-speciﬁc propensities of gaining damage. Therefore,
there is a lesser need for the patient level random effects in the Poisson mover–stayer models,
which is reﬂected through a larger estimated value of νˆ (equivalently the continuous part of the
CP distribution is estimated to have smaller variance) in the Poisson mover–stayer CP model.
If the overall baseline intensity in the Poisson mover–stayer CP model, ρˆ=νˆ, is to be similar to
the other models, ρˆ will then be required to take a larger value. This causes the estimated stayer
proportion exp.−ρˆ/ to take a smaller value.
When the Poisson mover–stayer gamma and IG models are the true models in scenario 2,
Table 4 indicates that the Poisson mover–stayer gamma model has estimated πˆ ≈ 0 in 28:7%
and 58:9% of simulated data sets respectively, whereas none of the other models estimate πˆ≈0
for any of the same simulated data sets. Similarly, when the zero-inﬂated models are the true
model in scenario 2, the Poissonmover–stayer gammamodel provides the greatest proportion of
estimates where πˆ≈0. As discussed, the Poisson mover–stayer gamma model has greater ability
to represent an arbitrary number of slow transitioning movers, and thus more information,
e.g. in the form of longer follow-up or a smaller proportion of slow transitioning movers (as
in scenario 1), is required for the Poisson mover–stayer gamma model to identify a non-zero
stayer proportion, if one exists, when compared with the other models. Conversely, as indicated
in scenario 2, particularly when the Poisson mover–stayer gamma model is the true model,
other models may greatly overestimate the stayer proportion with a relatively narrow conﬁdence
interval when many slow transitioning movers are contained in the data. This observation was
also veriﬁed even when no stayer population exists (results from this simulation study are not
shown). Overall, these results emphasize the difﬁculty of estimating a stayer proportion when
many slow transitioning movers exists. Models which are more able to represent an arbitrary
number of slow transitioning movers may be the most appropriate in estimating the stayer
proportion, because they are at less risk of overestimating the stayer proportion. But with
less informative data (because of many slow transitioning movers and limited follow-up) these
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models may suggest, in the extreme case, that πˆ ≈ 0 even if a stayer population exists, as seen
in scenario 2 where π =0:3. Models which are less able to represent slow transitioning movers
require signiﬁcantly less informative data to identify a non-zero stayer proportion; however,
such an estimate may be an overestimate of the true stayer proportion in the presence of slow
transitioning movers.
5. Patient and observation level random-effects models
5.1. Model description
The simulation studies demonstrated that widely varying stayer proportion estimates, as seen
in the motivating application, may result from the choice of structure and distributional as-
sumption of the random effects, the existence of many slow transitioning movers and lack of
information in the data. Nevertheless, the lack of ﬁt with the Poisson mover–stayer models
provides an additional complicating factor in interpreting the models for this application. As
the zero-inﬂated models provide a much improved ﬁt to the data, which suggests that time
varying unobserved heterogeneity could be present in the PA data, a natural progression would
be to provide this same adjustment for the Poisson mover–stayer models. This, as before, can
be achieved through the incorporation of observation level random effects. If this approach is
adopted, the patient level random effects will primarily be designed to introduce correlation
between patient observations, as opposed to previously, where it was also designed to capture
unobserved heterogeneity.
Let Ui and Uij be multiplicative patient level mover–stayer and observation level random
effects respectively. Assume that Dij is Poisson distributed with mean
uiuijΛij =uiuij.tij+1 − tij/λ0 exp.β′zij/:
Then, under the usual assumption that Ui and Uij are independent, the marginal likelihood for
patient i is{∫ ∞
0
mi−1∏
j=0
h.dij|ui;Λij/f.ui/dui
}ciÆ{
πi +
∫ ∞
0
mi−1∏
j=0
h.0|ui;Λij/f.ui/dui
}1−ciÆ
where ciÆ is as before and
h.d|ui;Λij/=
∫ ∞
0
.uijuiΛij/d exp.−uijuiΛij/
d!
g.uij/duij:
These models were examined with the three patient level mover–stayer random-effects distribu-
tions that were described in Section 3.1 and with the gamma distribution (with parameter θnb
as before) for the observation level random effects. The marginal likelihood was evaluated by
ﬁrst computing the integrations over the gamma observation level random effects, resulting in
NB models conditional on Ui, then using the integrate command to perform the integra-
tions over the patient level random effects. These models will be referred to as NB mover–stayer
models, and further qualiﬁcation, when needed, will again be through the addition of the type
of patient level random-effects distribution that is used. Note that the ZINB model is obtained
from the NB mover–stayer gamma and NB mover–stayer IG models when θ and 1=ψ = 0 res-
pectively, whereas the class of Poisson mover–stayer models is obtained when θnb =0. The same
explanatory variables are again considered for regression purposes.
5.2. Results
Table 5 displays the results from ﬁtting the three NB mover–stayer models. Covariate effects
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Table 5. Parameter estimates of associations with damaged joint counts and stayer probability estimates
obtained from fitting the NB mover–stayer (patient and observation level random-effects) models to 757
psoriatic arthritis patients
Results for the following models:
NB mover– NB mover– NB mover–
stayer gamma stayer IG stayer CP
Attained number of −0:036 .−0:07,−0:00087/ −0:053 .−0:098,−0:0084/ −0:0047 .−0:034, 0:025/
damaged joints
Current number of 0.087 (0.058, 0.12) 0.085 (0.055, 0.11) 0.093 (0.065, 0.12)
active joints
Arthritis duration 0.026 (0.0071, 0.044) 0.03 (0.0096, 0.051) 0.018 (0.0021, 0.034)
Age at onset of arthritis 0:0097 .−0:0062, 0:026/ 0:0093 .−0:0076, 0:026/ 0:0087 .−0:0051, 0:023/
λ0 0.058 (0.029, 0.12) 0.087 (0.041, 0.19) 1
θnb 6.52 (5.32, 8) 6.27 (5.07, 7.75) 7.17 (5.9, 8.71)
θ 3.11 (2.24, 4.33)
ψ 0.31 (0.14, 0.7)
ν 18.75 (9.78, 35.94)
ρ 1.06 (0.84, 1.34)
π 0.0025 (0, 1) 0.3 (0.18, 0.45) 0.34 (0.26, 0.43)
Log-likelihood −2249:91 −2249:9 −2253:89
estimated from this model structure also remain relatively stable across different random-effects
distributional assumptions. Furthermore, apart from the attained number of damaged joints,
the covariate effects are comparable with those produced by the ZINB model. The number of
damaged joints attainednowdemonstrates amuch smaller negative effect size than in thePoisson
mover–stayermodels (whengammaobservation level randomeffects are not included).Thismay
have resulted because the attained number of damaged joints and the patient level randomeffects
are more confounded than before; the patient level random effect is now primarily designed to
introduce correlation between patient observations. This would also suggest that there is (at
most) little effect of accounting for the number of joints at risk of damage for these models.
Fig. 2, which displays the proﬁle log-likelihood for π, demonstrates that the numerical op-
timization routine converged at the maximum of the proﬁle log-likelihoods of the NB mover–
stayer IG and NB mover–stayer CP models, but not for the NB mover–stayer gamma model.
The estimated value of π from the NB mover–stayer IG and CP models were 0:3 .0:18, 0:45/ and
0:34 .0:26, 0:43/ respectively and are therefore in much closer agreement than when observation
level random effects were not included, i.e. compared with the difference between the Poisson
mover–stayer IG and Poisson mover–stayer CP models. Both models again provide strong evi-
dence for the existence of a stayer population through the size and conﬁdence interval of πˆ. A
test of the null hypothesis H0 :π = 0 for the NB mover–stayer IG model resulted in p< 0:001,
thus providing convincing evidence to reject this null hypothesis. The maximum of the proﬁle
log-likelihood in Fig. 2 for the NB mover–stayer gamma model can again be seen as πˆ=0, with
a 95% likelihood ratio interval calculated as .0, 0:086/. Even after accounting for time varying
unobserved heterogeneity, the NB mover–stayer gamma model suggests the non-existence of a
stayer population and therefore its inferences through π are again vastly different from those
from the NB mover–stayer IG and CP models.
A (generalized) likelihood ratio test of H0 :θnb =0 resulted in p<0:001 for each of the ﬁtted
NB mover–stayer models, therefore suggesting that it is necessary to account for time varying
unobserved heterogeneity. The large decrease in log-likelihood values when compared with the
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Fig. 2. Plots of the profile log-likelihoods for π (, point at which the numerical optimization procedure
converged): (a) NB mover–stayer gamma; (b) NB mover–stayer IG; (c) NB mover–stayer CP
Poisson mover–stayer models also suggest a much improved ﬁt to the data. A comparison of
the observed and estimated incremental joint damage from these models now follows.
5.3. Comparison of the observed and estimated incremental joint damage
As in Section 3.5, eij.d/ can be obtained through
eij.d/= Γ.d +1=θˆ
nb
/
dΓ.1=θˆ
nb
/
(
uˆiθˆ
nb
Λˆij
1+ uˆiθˆnbΛˆij
)d (
1
1+ uˆiθˆnbΛˆij
)1=θˆnb
, d =1, : : : ,
where Λˆij and θˆ
nb
are the maximum likelihood estimates obtained in the previous subsection
and where uˆi (which is a function of πˆi) is the empirical Bayes estimate of the random effect as
described in Section 3.5.
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Table 6. Observed and estimated changes in joint counts from the NB mover–stayer models†
Increments of Observed Results for the following models:
damaged joints
NB mover– NB mover– NB mover–
stayer gamma stayer IG stayer CP
0 without previous 6044 5973.69 (0.83) 5972.84 (0.85) 5974.07 (0.82)
damage
0 with previous 2032 2032.16 (1.3×10−5) 2030.62 (0.00094) 2037.52 (0.015)
damage
1 250 338.87 (23.09) 341.17 (24.36) 334.35 (21.28)
2 97 88.16 (0.91) 87.56 (1.02) 88.62 (0.79)
3 28 36.5 (1.96) 36.16 (1.84) 36.53 (1.99)
4 26 18.85 (2.73) 18.74 (2.81) 18.68 (2.86)
5 17 11.06 (3.2) 11.07 (3.17) 10.88 (3.45)
6 8 7.07 (0.12) 7.12 (1.07) 6.91 (0.17)
7 6 4.81 (0.3) 4.87 (0.26) 4.67 (0.38)
8 7 3.42 (3.75) 3.49 (3.52) 3.31 (4.11)
>8 15 15.42 (0.01) 16.34 (1.1) 14.47 (0.02)
Total 8530 8530 (37.07) 8530 (38.06) 8530 (35.89)
†The estimated changes of d joint counts are calculated as e.d/ =ΣiΣjeij.d/. In parentheses are the Pearson
statistic contributions. These are obtained by squaring the difference between the observed and estimated changes
and then dividing by the estimated changes.
Table 6 displays the observed and estimated incremental joint damage from the NB mover–
stayer models. These models demonstrate a much improved ﬁt to the data when compared
with the Poisson mover–stayer models, which is consistent with the respective likelihood values.
From Table 6, it is interesting to observe that these models provide similar agreements between
estimated and observed increments of damaged joints across all categories. In particular, there
is some evidence that all three models still overestimate the category corresponding to one
incremental joint damage. Overall, the Pearson statistic was calculated as 37.07, 38.06 and
35.89 for the ﬁtted NB mover–stayer gamma, IG and CP models respectively.
6. Does a stayer population exist in the psoriatic arthritis data?
This paper was motivated by the desire to obtain empirical evidence to support the existence
or non-existence of a stayer population who cannot develop damaged hand joints. For this
purpose, we ﬁtted multiple mover–stayer models to a comprehensive psoriatic arthritis data set
and analysed their inferences, performance and features. As a result, reasonable ﬁtting models
and greater understanding about the interpretation of inferences were obtained. Overall, such
an analysis has instilled greater conﬁdence in the conclusions drawn.
When there are many slow transitioning movers (relatively to the number of patients), the
results of Section 4 indicate that estimating the stayer proportion can be problematic. Unfortu-
nately, this may have been so for the psoriatic arthritis data since similar results were observed
to those in scenario 2 of the simulation study. In particular, there were large discrepancies in the
estimated values of π between the ﬁttedmodels with patient level gamma random effects and the
other ﬁtted models. The primary difﬁculty results from the other ﬁtted models (those where the
distribution of the patient level random effects, if included, were not chosen to be gamma) being
less able to represent an arbitrary number of slow transitioningmovers, as discussed in Section 4,
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and therefore their estimated value of π may not represent only the proportion of stayers but also
the slow transitioning movers. Although the models with patient level gamma random effects,
which are less likely to overestimate the stayer proportion, may suggest the non-existence of a
stayer population even if a stayer population does exist; because π may become non-identiﬁable
for thesemodels when there aremany slow transitioningmovers. This was seen in the simulation
study under multiple settings from scenario 2, particularly when the Poisson mover–stayer IG
model was the true model and 58:9% of the simulated data sets produced values of πˆ ≈0 even
though the true value was π=0:3. Thewidely varying stayer proportion estimates of 0 (0, 0.086),
0.31 (0.18, 0.45) and 0.34 (0.26, 0.43) from the NB mover–stayer gamma, IG and CP models
respectively, which all provided reasonable ﬁts to the psoriatic arthritis data, therefore suggest
that there is inconclusive evidence to support the existence of a stayer population who cannot
develop damaged hand joints. Indeed, longer follow-up may demonstrate that the non-zero
stayer proportion estimates from the NB mover–stayer IG and CP models were in fact over-
estimates of the true stayer proportion, which may be 0, due to the slow transitioning movers,
whereas the NB mover–stayer gamma model may have suggested the non-existence of a stayer
population, even if one truly did exist, because of identiﬁability issues due to lack of follow-up
information. It is, however, important to note that the NB mover–stayer models are in strong
agreement regarding the existence of a minimal risk population, as suggested by the non-zero
estimated values of π and its corresponding conﬁdence interval from the NB mover–stayer IG
and CP models as well as the estimated shape of the gamma distribution (θˆ=3:11 .2:24, 4:33/)
from the NB mover–stayer gamma model. Such a population, in itself, may be of most clinical
interest especially because these patients are at a lower risk of developing immediate damage.
Identifying patients in this subset can then be facilitated through introducing covariates into
the model for π within the reasonable ﬁtting models, as discussed in Section 3.3.
7. Discussion
Mover–stayer counting process models are commonly used in the literature. In many instances,
a single model is ﬁtted (sometimes including the non-mover–stayer version) and conclusions
regarding a stayer population are drawn based solely on that model. This paper demonstrates
that, when ﬁtted to the same data, different mover–stayer models can lead to widely varying
stayer proportion estimates even if all the models provide reasonable ﬁts to the data, e.g. the
ﬁttedNBmover–stayermodels in themotivating application.Thus, if such ananalysis is adopted
uncritically, speciﬁc conclusions on a stayer population may be reached even though different
models ﬁtted to the same data may produce vastly different results.
A model’s ability to account adequately for slow transitioning movers is a worthwhile con-
sideration when estimation of a stayer proportion is of interest, i.e. whether the model for the
movers can adequately allow for an arbitrary number of patients who have constantly low
propensity to experience the event of interest, if these patients exist. Section 4 provides a discus-
sion for some of the most commonly used models. Models which are less able to account for an
arbitrary number of slow transitioning movers may not be able to provide an accurate estimate
of the stayer proportion, especially if there are many slow transitioning movers, because their
estimated value of π may not only represent stayers, as intended, but also patients who have a
minimal risk of the event of interest (which is not adequately accounted for in the model for
the movers). Fitting multiple mover–stayer models which are more and less able to account for
many slow transitioning movers can therefore contribute greater understanding or conﬁdence
regarding the composition of stayers and slow transitioning movers, which will probably be of
clinical interest in many cases since neither are likely to develop immediate damage. The simu-
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lation study demonstrated a potential pitfall regarding the use of mover–stayer models on less
informative data, e.g. because of relatively short follow-up, particularly the possibility that these
models suggest the non-existence of a stayer population even if such a population exists. Such
an observation may be seen as counterintuitive if the lack of sufﬁcient information in the data is
thought to manifest itself through large standard errors as opposed to greatly altering the point
estimate. This consideration may therefore be useful, especially if it leads to more appropriate
interpretation of πˆ. It should be noted, as was clearly seen in the simulation study, that models
which are more able to represent an arbitrary number of slow transitioning movers will prob-
ably require more informative data to suggest a non-zero stayer proportion, and therefore this
potential pitfall will be most relevant for these models such as those with patient level gamma
random effects. Additionally, it is useful to examine model goodness of ﬁt as this facilitates
understanding important characteristics of the distribution of events in the movers. Accounting
for these characteristics, such as observation level unobserved heterogeneity, may result in more
reasonable ﬁtting models therefore instilling greater conﬁdence in the inferences obtained, and
may also provide more similar estimates of π between competing models.
This work considered practical models that can be ﬁtted reasonably easily, because of closed
formmarginal likelihoods ormarginal likelihoods that canbe evaluatedbyusing a single integra-
tionperpatient, that accommodated important characteristics of thedata, suchaswithin-patient
correlation and time varying unobserved heterogeneity. Thus this work considered models that
have commonly been used, or are likely to be used in the future, to demonstrate potential pitfalls
that may occur if a single analysis regarding the existence of a mover–stayer scenario is adopted
uncritically. A natural extension would consist of developing more ﬂexible models, e.g. by using
random-effects structures that account for time varying unobserved heterogeneity, such as those
proposed in Aalen et al. (2008) and Unkel et al. (2014). Most of these random-effects struc-
tures when used in conjunction with intermittently observed Poisson processes and where the
follow-up is extensive, such as in the psoriatic arthritis data, will, however, result in an intractable
marginal likelihood, and therefore further research will probably be required. This work also
did not focus on predicting a new patient’s outcomes but instead focused on understanding the
outcomes from a speciﬁc set of patients. Thus the goodness-of-ﬁt test proposed, which utilized
in-sample prediction, did not penalize a model for overﬁtting the data. More appropriate model
assessment criteria for prediction, if it is of interest, would involve out-of-sample prediction or
other forms of penalty functions to identify overly complex models.
The results in this paper suggest that the models ﬁtted, taken together, do not provide conclu-
sive evidence for the existence of a stayer population who cannot develop damaged hand joints.
However, there is convincing evidence of a subpopulation of patients who are at least at minimal
risk of damage, where minimal risk is characterized by the ﬁtted models. An interesting area of
future work, at least from a clinical perspective, would be to characterize minimal risk directly
on the basis of clinical considerations, perhaps through specifying a threshold for the damage
progression rate, and then to develop models which can estimate the proportion of patients who
belong to this user-speciﬁed characterization. At a minimum, this will ensure that the target of
inference will be of clinical interest and perhaps estimation of π will be less model dependent
because π will be characterized by using a range of values of the damage progression rate and
not based solely on zero.
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